Duality of B Cell-CXCL13 Axis in Tumor Immunology.

Abstract

Tumor immunity is a rapidly evolving area of research consisting of many possible permutations of immune cell tumor interactions that are dependent upon cell type, tumor type, and stage in tumor progression. At the same time, the majority of cancer immunotherapies have been focused on modulating the T cell-mediated antitumor immune response and have largely ignored the potential utility that B cells possess with respect to tumor immunity. Therefore, this motivated an exploration into the role that B cells and their accompanying chemokine, CXCL13, play in tumor immunity across multiple tumor types. Both B cells and CXCL13 possess dualistic impacts on tumor progression and tumor immunity which is furthered detail in this review. Specifically, various B cells subtypes are able to suppress or enhance several important immunological functions. Paradoxically, CXCL13 has been shown to drive several pro-growth and invasive signaling pathways across multiple tumor types, while also, correlating with improved survival and immune cell tumor localization in other tumor types. Potential tools for better elucidating the mechanisms by which B cells and CXCL13 impact the antitumor immune response are also discussed. In addition, multiples strategies are proposed for modulating the B cell-CXCL13 axis for cancer immunotherapies.

• Authors: Angel J Rubio, Tyrone Porter, Xuemei Zhong
• Journal: Frontiers in immunology (Front Immunol) Vol. 11 Pg. 521110 ( 2020) ISSN: 1664-3224 [Electronic] Switzerland
• PMID: 33193299 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2020 Rubio, Porter and Zhong.

Chemical References

• CXCL13 protein, human
• Chemokine CXCL13
• Neoplasm Proteins

Topics

• Animals
• B-Lymphocytes (immunology, pathology)
• Chemokine CXCL13 (immunology)
• Humans
• Immunotherapy
• Neoplasm Proteins (immunology)
• Neoplasms (immunology, pathology, therapy)
• Tumor Microenvironment (immunology)